{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T05:56:20Z","timestamp":1794117380172,"version":"4.8.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Coronary allograft vasculopathy (CAV) remains a significant cause of morbidity and mortality after heart transplantation. The use of aspirin for CAV prophylaxis has recently garnered interest as a possible therapeutic adjunct in this setting.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>This 2-center retrospective cohort study included 372 patients who underwent heart transplantation between January 2009 and March 2018 and were stratified according to the commencement of aspirin during their index transplant admission. The primary outcome was the development of moderate or severe CAV (International Society for Heart and Lung Transplantation grade \u22652) at surveillance coronary angiography. Secondary endpoints included mortality at follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>There were no differences in age, sex, and cause of heart failure. In the early aspirin group, the preponderant risk factors included use of ventricular assist devices, pretransplant smoking, and mild or moderate rejection. Multivariable analyses to assess for independent predictors of CAV development and mortality demonstrated that aspirin was associated with reduced mortality (adjusted hazard ratio\u2005=\u20050.19; 95% confidence interval, 0.08-0.47, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.01) and a trend toward a protective effect against the development of moderate or severe CAV (adjusted hazard ratio\u2005=\u20050.24; 95% confidence interval, 0.54-1.19; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.08).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>In this retrospective risk-adjusted 2-center cohort study, early aspirin administration was associated with reduced risk of death and a trend toward a protective effect against CAV development. These findings warrant validation in prospective randomized trials.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000005131","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T04:00:31Z","timestamp":1721275231000},"page":"346-351","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Early Use of Aspirin for Coronary Allograft Prophylaxis in Heart Transplant Recipients"],"prefix":"10.1097","volume":"109","author":[{"given":"Cassia","family":"Kessler Iglesias","sequence":"first","affiliation":[{"name":"Heart Failure and Transplant Unit, Department of Cardiology, St Vincent\u2019s Hospital, Sydney, NSW, Australia."},{"name":"The Victor Chang Cardiac Research Institute, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason E.","family":"Bloom","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Alfred Health, Melbourne, VIC, Australia."},{"name":"Baker Heart and Diabetes Institute, Melbourne, VIC, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoman","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Alfred Health, Melbourne, VIC, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Moskovitch","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Alfred Health, Melbourne, VIC, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter","family":"Eckford","sequence":"additional","affiliation":[{"name":"Heart Failure and Transplant Unit, Department of Cardiology, St Vincent\u2019s Hospital, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Offen","sequence":"additional","affiliation":[{"name":"Heart Failure and Transplant Unit, Department of Cardiology, St Vincent\u2019s Hospital, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Kotlyar","sequence":"additional","affiliation":[{"name":"Heart Failure and Transplant Unit, Department of Cardiology, St Vincent\u2019s Hospital, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Keogh","sequence":"additional","affiliation":[{"name":"Heart Failure and Transplant Unit, Department of Cardiology, St Vincent\u2019s Hospital, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Jabbour","sequence":"additional","affiliation":[{"name":"Heart Failure and Transplant Unit, Department of Cardiology, St Vincent\u2019s Hospital, Sydney, NSW, Australia."},{"name":"The Victor Chang Cardiac Research Institute, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bergin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Alfred Health, Melbourne, VIC, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeline","family":"Leet","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Alfred Health, Melbourne, VIC, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Hare","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Alfred Health, Melbourne, VIC, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Alfred Health, Melbourne, VIC, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Hayward","sequence":"additional","affiliation":[{"name":"Heart Failure and Transplant Unit, Department of Cardiology, St Vincent\u2019s Hospital, Sydney, NSW, Australia."},{"name":"The Victor Chang Cardiac Research Institute, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Jansz","sequence":"additional","affiliation":[{"name":"Heart Failure and Transplant Unit, Department of Cardiology, St Vincent\u2019s Hospital, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Kaye","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Alfred Health, Melbourne, VIC, Australia."},{"name":"Baker Heart and Diabetes Institute, Melbourne, VIC, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Macdonald","sequence":"additional","affiliation":[{"name":"Heart Failure and Transplant Unit, Department of Cardiology, St Vincent\u2019s Hospital, Sydney, NSW, Australia."},{"name":"The Victor Chang Cardiac Research Institute, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavitha","family":"Muthiah","sequence":"additional","affiliation":[{"name":"Heart Failure and Transplant Unit, Department of Cardiology, St Vincent\u2019s Hospital, Sydney, NSW, Australia."},{"name":"The Victor Chang Cardiac Research Institute, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"R1-20250124","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.healun.2019.08.004","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult heart transplantation report\u20142019; focus theme: donor and recipient size match.","volume":"38","author":"Khush","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R2-20250124","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.healun.2016.08.017","article-title":"The Registry of the International Society for Heart and Lung Transplantation: thirty-third adult heart transplantation report\u20142016; focus theme: primary diagnostic indications for transplant.","volume":"35","author":"Lund","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"R3-20250124","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1097\/TP.0000000000002704","article-title":"Cardiac allograft vasculopathy: the enduring enemy of cardiac transplantation.","volume":"103","author":"Nikolova","year":"2019","journal-title":"Transplantation"},{"key":"R4-20250124","doi-asserted-by":"crossref","first-page":"e13769","DOI":"10.1111\/ctr.13769","article-title":"Recent advances in the role of mammalian target of rapamycin inhibitors on cardiac allograft vasculopathy.","volume":"34","author":"Bellumkonda","year":"2020","journal-title":"Clin Transplant"},{"key":"R5-20250124","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacc.2016.04.033","article-title":"Allograft vasculopathy: the Achilles\u2019 heel of heart transplantation.","volume":"68","author":"Chih","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R6-20250124","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1399-0012.2010.01307.x","article-title":"Cardiac allograft vasculopathy: current knowledge and future direction.","volume":"25","author":"Colvin-Adams","year":"2011","journal-title":"Clin Transplant"},{"key":"R7-20250124","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1161\/01.CIR.102.8.890","article-title":"Changes in surface expression of platelet membrane glycoproteins and progression of heart transplant vasculopathy.","volume":"102","author":"Fateh-Moghadam","year":"2000","journal-title":"Circulation"},{"key":"R8-20250124","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1046\/j.1399-0012.2003.00137.x","article-title":"Platelet activation in heart transplant recipients.","volume":"18","author":"Hognestad","year":"2004","journal-title":"Clin Transplant"},{"key":"R9-20250124","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1161\/CIRCULATIONAHA.108.840223","article-title":"Tobacco smoke exposure in either the donor or recipient before transplantation accelerates cardiac allograft rejection, vascular inflammation, and graft loss.","volume":"120","author":"Khanna","year":"2009","journal-title":"Circulation"},{"key":"R10-20250124","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9149(99)80432-9","article-title":"An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy.","volume":"75","author":"Mehra","year":"1995","journal-title":"Am J Cardiol"},{"issue":"5 Suppl","key":"R11-20250124","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1016\/j.healun.2004.03.009","article-title":"Cardiac allograft vasculopathy after heart transplantation: risk factors and management.","volume":"23","author":"Valantine","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"R12-20250124","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients.","volume":"42","author":"Velleca","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"R13-20250124","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jcmg.2016.10.021","article-title":"Layered fibrotic plaques are the predominant component in cardiac allograft vasculopathy: systematic findings and risk stratification by OCT.","volume":"10","author":"Clemmensen","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"R14-20250124","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/tri.13973","article-title":"Clinical implementation of coronary computed tomography angiography for routine detection of cardiac allograft vasculopathy in heart transplant patients.","volume":"34","author":"Nous","year":"2021","journal-title":"Transpl Int"},{"key":"R15-20250124","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.jacc.2014.01.071","article-title":"Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials.","volume":"63","author":"Wever-Pinzon","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R16-20250124","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1600-6143.2004.00434.x","article-title":"Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression.","volume":"4","author":"Caforio","year":"2004","journal-title":"Am J Transplant"},{"key":"R17-20250124","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.healun.2010.05.017","article-title":"International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010.","volume":"29","author":"Mehra","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R18-20250124","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jchf.2020.03.014","article-title":"Heart transplantation: an in-depth survival analysis.","volume":"8","author":"Hsich","year":"2020","journal-title":"JACC Heart Fail"},{"key":"R19-20250124","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1002\/sim.7501","article-title":"Practical recommendations for reporting Fine-Gray model analyses for competing risk data.","volume":"36","author":"Austin","year":"2017","journal-title":"Stat Med"},{"key":"R20-20250124","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.cardfail.2021.01.019","article-title":"Association of aspirin treatment with cardiac allograft vasculopathy progression and adverse outcomes after heart transplantation.","volume":"27","author":"Asleh","year":"2021","journal-title":"J Card Fail"},{"key":"R21-20250124","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.healun.2017.06.015","article-title":"Early aspirin use and the development of cardiac allograft vasculopathy.","volume":"36","author":"Kim","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R22-20250124","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/ctr.13133","article-title":"Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long-term follow-up.","volume":"31","author":"Peled","year":"2017","journal-title":"Clin Transplant"},{"key":"R23-20250124","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients.","volume":"42","author":"Velleca","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"R24-20250124","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pcad.2020.03.007","article-title":"Evidence-based pharmacotherapy for prevention and management of cardiac allograft vasculopathy.","volume":"63","author":"Mallah","year":"2020","journal-title":"Prog Cardiovasc Dis"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T14:01:32Z","timestamp":1737727292000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005131","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]}}}